Déprescription et santé durable : enseignements d’une journée interdisciplinaire (notice n° 2249331)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 06263cam a2200709 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260524000311.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Brunn, Matthias |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Déprescription et santé durable : enseignements d’une journée interdisciplinaire |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2026.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 92 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | La déprescription, entendue comme la réduction ou l’arrêt de médicaments inappropriés dans un objectif de qualité des soins, s’impose aujourd’hui comme un enjeu de santé publique majeur. Longtemps guidée par des considérations cliniques et économiques, elle intègre désormais une dimension environnementale croissante, liée notamment à l’empreinte écologique du cycle de vie des médicaments. Cet article présente une synthèse des enseignements issus d’une journée d’étude interdisciplinaire organisée à Sciences Po en décembre 2024, réunissant chercheurs, cliniciens, représentants institutionnels et acteurs du système de santé. Les discussions ont montré que la France reste un pays à forte consommation médicamenteuse, exposant les patients à des risques d’iatrogénie et générant des impacts environnementaux significatifs. Les intervenants ont souligné l’existence d’initiatives internationales structurées de déprescription, dont la transposition nécessite une adaptation au système de santé français. Malgré des efforts institutionnels portés par l’Assurance maladie, la HAS, l’ANSM ou les OMEDIT, différents obstacles persistent : manque de données consolidées, culture prescriptive ancrée, contraintes organisationnelles et attentes ambivalentes des patients. Des leviers d’action ont été identifiés, tels que la valorisation du travail de réévaluation, le développement d’outils d’aide à la décision acceptables pour les professionnels, les dynamiques territoriales pluriprofessionnelles et l’implication active des patients. Le cas des psychotropes illustre particulièrement la complexité de la déprescription. Au-delà des approches existantes, une stratégie nationale structurée apparaît nécessaire pour inscrire la déprescription dans une perspective de santé durable, articulant qualité des soins, équité et transition écologique. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Deprescribing, defined as the supervised reduction or discontinuation of inappropriate medications with the aim of improving quality of care, has become a major public health issue. Long guided primarily by clinical and economic considerations, deprescribing now increasingly incorporates an environmental dimension, particularly with regard to the ecological footprint of the pharmaceutical life cycle. This article presents a synthesis of key insights from an interdisciplinary workshop held at Sciences Po in December 2024, which brought together researchers, clinicians, institutional representatives, and health system stakeholders. The discussions highlighted that France remains a country with high levels of medication consumption, exposing patients to substantial risks of iatrogenesis while generating significant environmental impacts. Speakers emphasized the existence of structured international deprescribing initiatives, whose implementation in France would require adaptation to the specific features of the national health system. Despite institutional efforts led by the French National Health Insurance, the National Authority for Health, the National Agency for the Safety of Medicines and Health Products Safety, and regional observatories, several obstacles persist, including the lack of consolidated data, deeply rooted prescribing cultures, organizational constraints, and ambivalent patient expectations. Key levers for action were identified, such as greater recognition of medication review activities, the development of decision-support tools acceptable to health care professionals, the strengthening of territorially based multiprofessional dynamics, and the active involvement of patients. The case of psychotropic medications particularly illustrates the complexity of deprescribing practices. Beyond existing approaches, the discussions point to the need for a structured national strategy to embed deprescribing within a sustainable health framework, articulating quality of care, equity, and ecological transition. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | déprescription |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | médicaments |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | patients partenaires |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | politiques de santé |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pratiques professionnelles |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | psychotropes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | santé publique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | transition écologique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | deprescribing |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | ecological transition |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | health policy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | medications |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | patient involvement |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | professional practices |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | psychotropic drugs |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | public health |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nouguez, Étienne |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stahl, Eva |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cocard, Max |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Berna, Fabrice |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bouglé, Céline |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bouquet, Sylvain |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bounoure, Frédéric |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cabelguenne, Delphine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Castel, Patrick |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chirac, Pierre |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dariel, Odessa |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Depoux, Anneliese |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Duprat, Laura |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gigon, Emmanuel |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fournier, Jean-Pascal |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Halpern, Charlotte |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Huon, Jean-François |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kelley, Sophie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Laforest-Bruneaux, Agnès |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Leneel, Hervé |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Le Quinio, Pierre |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Masia, Charlotte |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Musso, Maeva |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Or, Zeynep |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Planel, Maurice-Pierre |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Santucci, Raoul |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Senn, Nicolas |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thierry, Jean-Pierre |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Traon, Claire |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Santé Publique | 38 | 2 | 2026-05-15 | p. 153-159 | 0995-3914 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/revue-sante-publique-2026-2-page-153?lang=fr&redirect-ssocas=7080">https://stm.cairn.info/revue-sante-publique-2026-2-page-153?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux